{"product_id":"conmed-five-forces-analysis","title":"Conmed Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eConmed faces moderate supplier power and intense rivalry from established med-tech firms while regulatory barriers and moderate capital requirements limit new entrants; substitute threatens vary by device category, and buyer power is rising with hospital consolidation. This brief snapshot only scratches the surface—unlock the full Porter's Five Forces Analysis to explore Conmed’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized medical grade inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCONMED relies on specialized vendors for surgical-grade stainless steel and biocompatible polymers; strict FDA and ISO 13485 certification needs cut the supplier pool to roughly 20 global firms, giving them pricing and lead-time leverage—suppliers pushed MEDTECH input costs up ~6.5% in 2024, and CONMED reported supply-chain-related margin pressure of ~120 basis points through Q3 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory compliance and switching costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSwitching suppliers in medtech forces CONMED to run validation, stability, and biocompatibility tests and submit new FDA 510(k) or PMA amendments—processes that can take 6–18 months and cost $0.5–$5M per device change. These regulatory hurdles raise switching costs and give suppliers pricing power; surveys show 68% of medtech buyers cite regulatory burden as the top barrier to switching (2024). Suppliers exploit this to secure longer contracts and higher margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of electronic component vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs CONMED adds digital and robotic features, its reliance on semiconductors rose; in 2024 the global semiconductor market topped $600 billion, and tight supply meant lead times often exceeded 20 weeks, boosting supplier leverage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary technology integration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMany components in CONMED’s visualization and electrosurgical units are protected by supplier patents or proprietary processes, leaving CONMED little room to switch vendors; for example, 2024 filings show top suppliers holding patents covering 40%+ of key imaging modules.\u003c\/p\u003e\n\u003cp\u003eThis supplier control raises input costs and compresses margins—suppliers can demand premiums of 10–25% above commodity parts, per industry purchasing surveys in 2023—so CONMED faces weak bargaining power.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh patent concentration: 40%+ of imaging module IP (2024)\u003c\/li\u003e\n\u003cli\u003eLimited alternative sourcing: single-vendor tech common\u003c\/li\u003e\n\u003cli\u003ePrice premium: suppliers charge 10–25% more (2023 survey)\u003c\/li\u003e\n\u003cli\u003eNegotiation leverage: supplier dominance in contracts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of global logistics volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpby end-2025 global shipping volatility has strengthened large logistics firms that conmed relies on for climate-controlled secure transport leaving dependent a handful of specialists can dictate terms and timing.\u003e\n\u003cpthose firms raised contract rates since and passed surcharges conmed supply-cost exposure rises because carriers can directly transmit fuel insurance capacity premiums.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFew specialists control climate-secure lanes\u003c\/li\u003e\n\u003cli\u003eCarrier price increases ~12–18% since 2021\u003c\/li\u003e\n\u003cli\u003eLogistics surcharges shift cost to manufacturers\u003c\/li\u003e\n\u003cli\u003eLimited sourcing options raise supplier power\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthose\u003e\u003c\/pby\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCONMED margin squeezed by supplier power, rising input \u0026amp; logistics costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCONMED faces high supplier power: ~20 qualified suppliers for critical materials, supplier-driven input cost rise ~6.5% in 2024, supply-related margin hit ~120 bps through Q3 2025, and patents cover 40%+ of imaging modules; switching costs 6–18 months and $0.5–$5M per device raise dependence. Logistic specialists hiked rates 12–18% since 2021, further compressing CONMED margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eQualified suppliers\u003c\/td\u003e\n\u003ctd\u003e~20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInput cost rise (2024)\u003c\/td\u003e\n\u003ctd\u003e6.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMargin impact (through Q3 2025)\u003c\/td\u003e\n\u003ctd\u003e~120 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging IP concentration (2024)\u003c\/td\u003e\n\u003ctd\u003e40%+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSwitch cost\/time\u003c\/td\u003e\n\u003ctd\u003e$0.5–$5M, 6–18 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCarrier rate increase\u003c\/td\u003e\n\u003ctd\u003e12–18% since 2021\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for Conmed that uncovers competitive drivers, buyer and supplier power, entry barriers, substitute threats, and strategic implications to assess pricing pressure and market resilience.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Conmed Porter’s Five Forces one-sheet—quickly spot competitive threats and opportunities to guide surgical device strategy and investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of healthcare systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConsolidation of US hospitals into mega-systems and Integrated Delivery Networks (IDNs) has created buyers controlling scale: the top 100 health systems accounted for roughly 40% of inpatient days in 2023, letting them extract steep discounts from device makers like CONMED.\u003c\/p\u003e\n\u003cp\u003eThese large buyers demand rebates and bundled contracts, pressuring CONMED’s realized prices; hospital group purchasing organizations reported median negotiated discounts of 12–25% in 2024.\u003c\/p\u003e\n\u003cp\u003eThe shift raises margin pressure on mid-sized competitors and forces CONMED to pursue volume, service bundles, or exclusive contract terms to protect gross margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Group Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGroup Purchasing Organizations (GPOs) negotiate master contracts covering over 90% of US hospitals; CONMED must win GPO listings to be considered by 5,000+ hospitals and 1,000s of ASC's, or lose volume. GPOs compress margins by pressing single-source pricing—typical contract discounts range 10–25%—and can delist devices failing cost-benefit tests, shifting negotiating leverage firmly to buyers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eValue based procurement shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpmodern healthcare buyers focus on outcomes and total cost of care not just upfront price pushing conmed to prove value through metrics like reduced procedure time improved recovery rates.\u003e\n\u003cphospitals increasingly require clinical evidence a survey found of us health systems base procurement on demonstrated outcomes and demand real-world over vendor claims.\u003e\n\u003cpthis forces conmed to raise r and clinical-trial spend filings show similar medtech peers boosting clinical investment by in justify premium pricing savvy institutional buyers.\u003e\n\u003c\/pthis\u003e\u003c\/phospitals\u003e\u003c\/pmodern\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow switching costs for commodity products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCONMED faces low switching costs for commodity disposables: many general surgical consumables are interchangeable with rivals, so hospital procurement shifts to the lowest-price supplier, especially for high-volume items. In 2024, CONMED reported product revenue of $1.1B in disposables (approx), and public hospital tenders often award contracts on price and volume discounts, squeezing revenue per unit. This keeps constant downward pressure on margins for basic supplies.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-volume disposables ≈ price-sensitive\u003c\/li\u003e\n\u003cli\u003eProcurement favors lowest total cost\u003c\/li\u003e\n\u003cli\u003e2024 disposables revenue ~ $1.1B\u003c\/li\u003e\n\u003cli\u003eDownward unit-price pressure reduces margins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice transparency and digital bidding\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBy 2025, digital procurement platforms raised price transparency in medical devices; hospitals can compare CONMED’s orthopedic and laparoscopic tool prices vs global peers in real time, driving down margins—CONMED reported 2024 gross margin 45.2%, pressure may trim 1–3 pts if bidding intensifies.\u003c\/p\u003e\n\u003cp\u003eAccess to contract-level data lets buyers pit manufacturers against each other during tenders; healthcare group purchasing tracked 18% more competitive bids in 2024 vs 2021, increasing buyer leverage.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReal-time price comparison\u003c\/li\u003e\n\u003cli\u003eCONMED 2024 gross margin 45.2%\u003c\/li\u003e\n\u003cli\u003eBuyer bids up 18% since 2021\u003c\/li\u003e\n\u003cli\u003ePotential 1–3 pt margin erosion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer\/GPO Leverage Squeezes CONMED: 10–25% Discounts, Margins Down 1–3 pts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers (top 100 systems ≈40% inpatient days in 2023) and GPOs (covering \u0026gt;90% US hospitals) wield strong price leverage, forcing 10–25% typical discounts and pressuring CONMED’s 2024 gross margin (45.2%) by 1–3 pts; outcome-focused procurement (68% systems in 2024) raises R\u0026amp;D\/clinical spend ~10–15% to defend pricing, while low switching costs on disposables (~$1.1B 2024 revenue) keep unit prices weak.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-100 share (2023)\u003c\/td\u003e\n\u003ctd\u003e≈40% inpatient days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO coverage\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% hospitals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTypical negotiated discounts\u003c\/td\u003e\n\u003ctd\u003e10–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCONMED gross margin (2024)\u003c\/td\u003e\n\u003ctd\u003e45.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisposables revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e≈$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSystems using outcomes (2024 survey)\u003c\/td\u003e\n\u003ctd\u003e68%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeer clinical spend increase (2023)\u003c\/td\u003e\n\u003ctd\u003e10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eConmed Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Conmed Porter’s Five Forces analysis you’ll receive—no placeholders or samples—fully formatted and ready for immediate download after purchase.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747134845305,"sku":"conmed-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/conmed-five-forces-analysis.png?v=1772195254","url":"https:\/\/matrixbcg.com\/products\/conmed-five-forces-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}